Illumina, Inc. has sequenced the DNA of American actress Glenn Close, the first publicly named female to have her DNA sequenced to full coverage.
Media reports indicated drugstore chain Walgreen Co. is in talks about a plan to offer prescription drugs directly to employees of Delta Air Lines Inc.
The pharmaceutical industry's main trade group spent $6.3 million in the fourth quarter lobbying Congress, the White House and multiple government agencies on health care provisions and related issues, according to a quarterly disclosure report.
Moody's Investors Service affirmed its ratings and negative outlook for Abbott Laboratories and warned of a potential downgrade, citing the company's decision to buy Facet Biotech Corp. for $450 million.
Top Democrats say they are resolving disputes over President Barack Obama's health overhaul plan, but they face decisions on subsidizing coverage and are still hunting votes to push the vast package through Congress.
Caraco Pharmaceutical Laboratories Ltd. said it launched a generic version of Sanofi-Aventis' cancer treatment Eloxatin.
Pfizer Inc. said the cancer drug Sutent did not meet key goals in two late-stage studies focusing on advanced breast cancer.
The Numerical Algorithms Group will mark its 40th anniversary in 2010 by expanding its student prize program, with a new awards intended to cultivate the next generation of numerical software talent worldwide.
Lab901 announced a significant extension of the user base for its protein ScreenTape platform for rapid, convenient, automated SDS-PAGE.
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer.
People with occasional spikes in their blood pressure could be at higher risk of having a stroke than those with regularly high blood pressure, new studies said.
Pfizer Inc. said it discontinued a late-stage study of the drug candidate figitumumab in patients with late-stage lung cancer, citing a lack of effectiveness.
BD Biosciences, a segment of BD, announced the launch of the BD FACSAria III Cell Sorting System, a next-generation flow cytometer with the ability to run complex multicolor experiments using up to six lasers.
Thermo Fisher Scientific Inc., a leader in serving science, has introduced new lines to its Thermo Scientific Hamilton Infinity and Advantage Fume Hoods.
Algeta ASA, the cancer therapeutics company, announces that it has treated the first patient in a phase 2 clinical study with Alpharadin for bone metastases resulting from endocrine-refractory breast cancer.